General Provisions.
Current text · Edition through November 18, 2026
General Provisions.
(b) A research license shall not be required for:
(1) research and development activities conducted by licensees, permittees, or registrants approved by the Board, provided that the research activities are within the scope of their existing license type;
(2) data only studies that do not directly involve human subjects or use of investigational product directly or in any whole or processed form; or
(3) studies conducted using federally sourced cannabis supplied by the National Institute on Drug Abuse Drug Supply Program, provided that the researcher supplies the Office with documentation of such federal approvals once received.
(d) A research licensee may:
(i) a licensee or permittee approved by the Board under Article 4 and 6 of the Cannabis Law;
(ii) a cannabis testing laboratory permitted by the Board;
(iii) a registered organization;
(iv) another research licensee;
(v) key personnel or a human subject, as part of, and in compliance with, the conditions of an approved research project; or
(vi) individuals or entities as approved by the Board.
(ii) to conduct genomic research;
(iii) to test chemical potency and composition levels;
(iv) to conduct clinical investigations with investigational products, including human observational studies;
(v) to conduct research on the efficacy and safety of administering investigational products as a component of medical treatment; or
(vi) other research topics approved by the Board that comply with Cannabis Law section 38.
(i) the research licensee receives prior written approval from the Board;
(ii) all investigational products used for research purposes are physically segregated and designated as such; and
(iii) inventory records pertaining to research can be distinguished from other records.
(e) A research licensee shall not, for the purposes of fulfilling the authorizations under this license:
(1) obtain or transport investigational products outside of New York State;
(2) acquire investigational products from a person other than a licensee, permittee or registrant approved by the Board, unless approved by the Board; or
(f) An applicant shall demonstrate to the Board that there are effective procedures to safeguard against diversion, theft or loss of investigational products, including proving that the security measures are adequate for storing the quantity of investigational products the research licensee may have in possession.
(h) Access to stored investigational products, whether ambient or refrigerated, must be restricted to the principal investigator and key personnel.
(i) A research licensee shall:
Source details
- Title agency
- Executive Department
- Section status
- Section text
- Edition through
- Nov 18, 2026
- Text saved
- Nov 9, 2026
- Latest issue in our Register collection
- November 18, 2026 (Vol. XLVIII, Issue 46)
- Related filing
- Adopted rule · OCM-14-23-00011-A
- Related notice published
- Aug 9, 2023
- Related notice effective date
- Aug 9, 2023